Technosphere insulin suppresses endogenous glucose production earlier than a rapid-acting analogue (lispro) and an inhaled insulin (Exubera®)

被引：0
|
作者：
Potocka, E.
Hovorka, R. [1 ]
Baughman, R.
Umpleby, M. [2 ]
Diaz, M.
Chen, R.
Cassidy, J.
Boss, A.
Richardson, P.
机构：
[1] Univ Cambridge, Metab Res Labs, Cambridge CB2 1TN, England
[2] Univ Surrey, Guildford GU2 5XH, Surrey, England
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
952
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [31] Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects
    Becker, RHA
    Frick, AD
    Burger, F
    Potgieter, JH
    Scholtz, H
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (08) : 435 - 443
  • [32] Rapid-Acting Insulin Analog Rather Than Short-Acting Insulin, Can Decrease Wound Infection Risk With Controlling Blood Glucose Drifting in the Surgical Diabetic Patients
    Ueno, Hiroki
    Hosoi, Masayuki
    Yoshida, Yoko
    Yakushizi, Yosuke
    Hosokawa, Yuki
    Tanaka, Nagaaki
    Yamagami, Keiko
    Kawasaki, Isao
    Hiura, Yoshikazu
    [J]. DIABETES, 2012, 61 : A552 - A552
  • [33] Fast acting insulin analog (LISPRO) improves glucose tolerance of NIDDM by inhibiting hepatic glucose production
    Bruttomesso, D
    Pianta, A
    Valerio, A
    Tadiotto, F
    Lavagnini, T
    DelPrato, S
    [J]. DIABETES, 1996, 45 : 513 - 513
  • [34] Pharmacokinetics and pharmacodynamics of the rapid-acting analogue insulin Aspart in pediatric/adolescent patients with type I diabetes
    Olsen, B
    Lindholm, A
    Mortensen, H
    Hylleberg, B
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 136A - 136A
  • [35] The effect of preprandial vs. postprandial administration of rapid-acting insulin analogue on continuous glucose monitoring in type 1 diabetic patients
    Gelber, A.
    Liberty, I. F.
    Perry, Z. H.
    Botach, E.
    Harman-Boehm, I.
    [J]. DIABETOLOGIA, 2008, 51 : S436 - S437
  • [36] Maternal glucose control and perinatal outcomes of pregnancy with impaired glucose tolerance in using rapid acting insulin analogue insulin aspart
    Sugiyama, Takashi
    Murabayashi, Nao
    Umekawa, Takashi
    Nagao, Kenji
    Kamimoto, Yuki
    Sugihara, Taku
    Sagawa, Norimasa
    [J]. DIABETES, 2007, 56 : A703 - A703
  • [37] Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type2 diabetes mellitus
    Kuroda, Akio
    Kaneto, Hideaki
    Kawashima, Satoshi
    Sakamoto, Kenya
    Takahara, Mitsuyoshi
    Shiraiwa, Toshihiko
    Yasuda, Tetsuyuki
    Katakami, Naoto
    Matsuoka, Taka-aki
    Shimomura, Iichiro
    Matsuhisa, Munehide
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (01): : 78 - 81
  • [38] Mealtime rapid-acting inhaled insulin (Exubera®) improves glycemic control in patients with type 2 diabetes failing combination oral agents:: A 3-month, randomized, comparative trial
    Rosenstock, J
    [J]. DIABETES, 2002, 51 : A132 - A133
  • [39] Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
    Choe, Eun Yeong
    Lee, Yong-Ho
    Lee, Byung-Wan
    Kang, Eun-Seok
    Cha, Bong Soo
    Lee, Hyun Chul
    [J]. DIABETES & METABOLISM JOURNAL, 2012, 36 (03) : 230 - 236
  • [40] COMPARISON OF PHARMACOKINETIC PROPERTIES, PHYSICOCHEMICAL STABILITY, AND PUMP COMPATIBILITY OF 3 RAPID-ACTING INSULIN ANALOGUES-ASPART, LISPRO, AND GLULISINE
    Bode, Bruce W.
    [J]. ENDOCRINE PRACTICE, 2011, 17 (02) : 271 - 280
12345